•  
  •  
 

Abstract

Background: Leprosy remains a significant public health concern in endemic regions such as Indonesia. Children are particularly vulnerable due to their naive immunity and close familial contacts. This study aims to report cases of pediatric leprosy in Lembata, Indonesia, focusing on clinical characteristics and associated risk factors.

Case Illustration: A case series of eight pediatric patients (<15 >years) diagnosed with leprosy was conducted during a community-based screening program in Lembata, Indonesia, in 2022. Of 140 individuals examined, 8 were children. Most patients were male (6/8) with a mean age of 11.75 years. Multibacillary (MB) leprosy predominated (7/8), and a history of household contact was identified in 6/8 cases. Skin lesions were present in all patients, with nerve involvement in 6/8. Leprosy reactions occurred in 2/8 cases, predominantly erythema nodosum leprosum. Ocular involvement was generally mild, with normal visual acuity in most cases. Ear, nose, and throat findings included atrophic rhinitis, cerumen impaction, and nasopharyngeal inflammation. One patient presented with World Health Organization grade 2 disability of the extremities.

Discussion: The predominance of MB cases and the high proportion of household contact suggest delayed diagnosis and ongoing transmission within families. The relatively mild ocular findings may reflect shorter disease duration prior to treatment. These findings highlight gaps in early detection and contact tracing in endemic settings.

Conclusion: Pediatric leprosy in Lembata, Indonesia, presents with diverse clinical presentations, often leading to delayed diagnosis and treatment. Familial transmission highlights ongoing challenges in leprosy control and the importance of early detection and treatment.

References

  1. Le PH, Philippeaux S, Mccollins T, et al. Pathogenesis, clinical considerations, and treatments: A narrative review on leprosy. Cureus. 2023;15(12):1–7.

  2. Samosir PM, Axelia PG, Alkaff FF, Salamah SS, Alinda MD. Prevalence and risk factors for disability in leprosy patients in Indonesia during the post-elimination era. Dermatol Reports. 2023;15(4):1–7.
  3. World Health Organization. Leprosy [Internet]. Geneva: World Health Organization; 2024 [cited 2024 Jul 12]. Available from: https://www.who.int/news-room/fact-sheets/detail/leprosy
  4. World Health Organization. Towards zero leprosy: Global leprosy (Hansen’s disease) strategy 2021–2030 [Internet]. New Delhi: World Health Organization; 2021 [cited 2024 Jul 12]. Available from: https://www.who.int/publications-detail-redirect/9789290228509
  5. World Health Organization. Global leprosy (Hansen disease) update, 2019: Time to step-up prevention initiatives. Weekly Epidemiological Record. 2020;95(36):417–440.
  6. World Health Organization. Leprosy elimination: Indicators to be monitored and post-elimination surveillance [Internet]. Geneva: World Health Organization; 2020 [cited 2024 Jul 12]. Available from: https://www.who.int/docs/default-source/ntds/leprosy/global-consultation-on-global-leprosy-strategy-2021-2030/18-elimination-indicators.pdf
  7. Kementerian Kesehatan Republik Indonesia. Laporan validasi data kusta tahun 2021 [Internet]. Jakarta: Direktorat P2PM Kementerian Kesehatan Republik Indonesia; 2021 [cited 2024 Jul 9]. Available from: https://p2pm.kemkes.go.id/storage/informasi-publik/content/informasi-publik_18_20220718073519.pdf
  8. Teixeira CS, Pescarini JM, Alves FJ, et al. Incidence of and factors associated with leprosy among household contacts of patients with leprosy in Brazil. JAMA Dermatol. 2020;156(6):640–8.
  9. Vieira MC, Nery JS, Paixão ES, Freitas de Andrade KV, Penna GO, Teixeira MG. Leprosy in children under 15 years of age in Brazil: A systematic review of the literature. PLoS Negl Trop Dis. 2018;12(10):1–13.
  10. Darlong J, Govindharaj P, Darlong F, Mahato N. A study of untreated leprosy affected children reporting with grade 2 disability at a referral centre in West Bengal, India. Lepr Rev. 2017;88:298–305.
  11. Irawati Y, Menaldi SL, Harini M, et al. A multidimensional welfare status of leprosy patients living in a suburban area. ASEAN Journal of Community Engagement. 2021;5(1):71–104.
  12. Moraes PC, Eidt LM, Koehler A, Ransan LG, Scrofeneker ML. Epidemiological characteristics of leprosy from 2000 to 2019 in a state with low endemicity in southern Brazil. An Bras Dermatol. 2023;98(5):602–10.
  13. Ghunawat S, Relhan V, Mittal S, Sandhu J, Garg VK. Childhood leprosy: A retrospective descriptive study from Delhi. Indian J Dermatol. 2018;63(6):455–8.
  14. Gitte SV, Ramanath NS, Kamble KM. Childhood leprosy in an endemic area of Central India. Indian Pediatr. 2016;53(3):221–4.
  15. Mahajan S, Sardana K, Bhushan P, Koranne RV, Mendiratta V. A study of leprosy in children, from a tertiary pediatric hospital in India. Lepr Rev. 2006;77(2):160–2.
  16. Sarkar T, Sarkar S, Patra AC, et al. BCG vaccination: Effects on the patterns of pediatric leprosy. J Family Med Prim Care. 2020;9(7):3673–6.
  17. Oliveira MB, Diniz LM. Leprosy among children under 15 years of age: Literature review. An Bras Dermatol. 2016;91(2):196–203.
  18. Abeje T, Negera E, Kebede E, et al. Performance of general health workers in leprosy control activities at public health facilities in Amhara and Oromia States, Ethiopia. BMC Health Serv Res. 2016;16:1–7.
  19. Rahayu T, Lestari YD, Irawati Y, et al. Leprosy health promotion during COVID-19 pandemic in Indonesia. J Community Empower Health. 2024;7(1):1–5.
  20. Narang T, Kumar B. Leprosy in children. Indian J Paediatr Dermatol. 2019;20(1):12–24.
  21. Zhu J, Yang D, Shi C, Jing Z. Case Report: Therapeutic dilemma of refractory erythema nodosum leprosum. Am J Trop Med Hyg. 2017;96(6):1362–4.
  22. Pavezzi PD, do Prado RB, Boin Filho PÂ, et al. Evaluation of ocular involvement in patients with Hansen’s disease. PLoS Negl Trop Dis. 2020;14(9):1–14.
  23. Irawati Y, Lestari DY, Bani AP, Menaldi SL, Wahyuni LK, Kurniawardhani DR. Health care service for leprosy patients in Sitanala Tangerang (A proposed approach of comprehensive health care for leprosy patient). ASEAN Journal of Community Engagement. 2018;2(2):281–97.
  24. Biswas J, Pradhan A. Ocular lesions in leprosy – Should we forget? Indian J Ophthalmol. 2022;70(7):2673–4.
  25. Rathinam SR, Parikh JG, Rao NA. Ocular erythema nodosum leprosum: An immunohistochemical study. Indian J Ophthalmol. 2020;68(9):2028–30.
  26. Grzybowski A, Nita M, Virmond M. Ocular leprosy. Clin Dermatol. 2015;33(1):79–89.
  27. Rumbaut Castillo R, Hurtado Gascón LC, Ruiz-Fuentes JL, et al. Leprosy in children in Cuba: Epidemiological and clinical description of 50 cases from 2012-2019. PLoS Negl Trop Dis. 2021;15(10):1–13.
  28. Gunawan H, Kamilia A, Menaldi SL, et al. Characteristics of grade 2 disability in Indonesian children with leprosy: A five-year multicenter retrospective study. Clin Cosmet Investig Dermatol. 2021;14:1149–53.
  29. Ploemacher T, Faber WR, Menke H, Rutten V, Pieters T. Reservoirs and transmission routes of leprosy; A systematic review. PLoS Negl Trop Dis. 2020;14(4):1–27.
  30. Sun WH, Li YR, Fang TY. Leprosy manifesting as nasal obstruction and epistaxis. J Formos Med Assoc. 2018;117(11):1032–3.
  31. Rathod SP, Jagati A, Chowdhary P. Disabilities in leprosy: An open, retrospective analyses of institutional records. An Bras Dermatol. 2020;95:52–6.
  32. Fwoloshi S, Machona SM, Mudenda V, Ngalamika O. Laryngeal involvement causing dysphonia in a 29 year old nursing mother with lepromatous leprosy. Pan Afr Med J. 2015;21:1–5.
  33. Morgado de Abreu MA, Nai GA, Molina JD, Gomes RT, de Paula N, Roselino AM. Mycobacterium leprae on palatine tonsils and adenoids of asymptomatic patients, Brazil. Emerg Infect Dis. 2020;26(10):2518–20.

Additional Files
#1237_Rev_v1_Exploring Pediatric Leprosy_6th Apr 2026.docx (64 kB)
Revise Submission_Minor Revision
Download

Share

COinS